Literature DB >> 2947909

Atrial natriuretic peptide in hypothyroidism.

R S Zimmerman, H Gharib, D Zimmerman, D Heublein, J C Burnett.   

Abstract

The effect of hypothyroidism on circulating levels of atrial natriuretic peptide (ANP) was studied in 11 hypothyroid patients (aged 11-65 yr; mean, 31 yr) and 13 normal subjects (aged 28-39 yr; mean, 32 yr). Plasma ANP was 32 +/- 9 (+/- SD) pg/ml in normal subjects and 20 +/- 5 pg/ml in the hypothyroid patients (P less than 0.005). In 7 hypothyroid patients, plasma ANP levels were measured after 10-14 weeks of L-T4 therapy. ANP increased from 22 +/- 5 to 46 +/- 18 pg/ml (P less than 0.02), along with an increase in mean serum T4 from 0.6 +/- 0.5 to 8.1 +/- 2.5 micrograms/dl (P less than 0.001). Thus, hypothyroidism is characterized by decreased circulating levels of ANP which are reversed by L-T4 therapy.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2947909     DOI: 10.1210/jcem-64-2-353

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  8 in total

1.  Raised plasma levels of atrial natriuretic peptides in Addison's disease.

Authors:  F P Cappuccio; N D Markandu; M G Buckley; A L Sugden; G A Sagnella; G A MacGregor
Journal:  J Endocrinol Invest       Date:  1989-03       Impact factor: 4.256

2.  The effect of iron overload in the hearts of patients with beta-thalassemia.

Authors:  S V Brili; A I Tzonou; S S Castelanos; C J Aggeli; C A Tentolouris; C E Pitsavos; P K Toutouzas
Journal:  Clin Cardiol       Date:  1997-06       Impact factor: 2.882

3.  Responses of plasma human atrial natriuretic factor to high intensity submaximal exercise in the heat.

Authors:  W J Kraemer; L E Armstrong; R W Hubbard; L J Marchitelli; N Leva; P B Rock; J E Dziados
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1988

4.  Plasma concentrations of atrial natriuretic peptide in hypothyroidism.

Authors:  A S Woolf; P J Moult
Journal:  Br Med J (Clin Res Ed)       Date:  1988-02-20

5.  Thyroid hormone replacement therapy for primary hypothyroidism leads to significant improvement of renal function in chronic kidney disease patients.

Authors:  Yuji Hataya; Shuta Igarashi; Takafumi Yamashita; Yasato Komatsu
Journal:  Clin Exp Nephrol       Date:  2012-11-17       Impact factor: 2.801

6.  Thyrotropin-releasing hormone increases plasma atrial natriuretic peptide levels in human.

Authors:  O Sergev; K Rácz; I Varga; R Kiss; L Fütö; K Mohari; E Gláz
Journal:  J Endocrinol Invest       Date:  1990-09       Impact factor: 4.256

Review 7.  Atrial natriuretic factor: physiologic actions and implications in congestive heart failure.

Authors:  B S Edwards; R S Zimmerman; J C Burnett
Journal:  Cardiovasc Drugs Ther       Date:  1987       Impact factor: 3.727

8.  Thyroid function modifies the association between ratio of triglyceride to high-density lipoprotein cholesterol and renal function: a multicenter cross-sectional study.

Authors:  Zhongshang Yuan; Meng Zhao; Bingchang Zhang; Haiqing Zhang; Xu Zhang; Qingbo Guan; Guang Ning; Ling Gao; Fuzhong Xue; Jiajun Zhao
Journal:  Sci Rep       Date:  2015-07-16       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.